THE Role of Chewable Tablets: An Overview

Eprosartan, LC/MS-MS, Validation, Plasma

Authors

  • Santosh Kumar Bhatt Department of pharmaceutics, Oxbridge college of Pharmacy, Bengaluru -560091, Karnataka, India
  • Kedarnagalakshman M Department of pharmaceutics, Oxbridge college of Pharmacy, Bengaluru -560091, Karnataka, India
  • Mukesh Sharma Department of pharmaceutics, Oxbridge college of Pharmacy, Bengaluru -560091, Karnataka, India

DOI:

https://doi.org/10.22270/ajprd.v9i4.1005

Keywords:

chewable tablet, lubrication, disintegration, compressibility etc.

Abstract

Chewable dosage forms for example tablets, delicate, pills, gums, chewable squares is long piece of drug specialist armamentarium. They are required to be break and bit in the middle of the teeth before administration. These tablets are given to the children who have difficulty in swallowing and to the adults who dislike swallowing. These tablets are intended to disintegrate smoothly in the mouth at a moderate rate either with or without actual chewing, characteristically chewable tablets have a smooth texture upon disintegration, are pleasant tasting and leave no bitter or unpleasant taste. Geriatric and pediatric patients and travelling patients who may not have ready access to water are most need of easy swallowing dosage forms like chewable tablets. The major formulation factors are flow, lubrication, disintegration, organoleptic properties, compressibility, compatibility and stability, which are common to regular (swallowed) and chewable tablets; however, organoleptic properties of the active drug substances are primary concern here. A formulator may use one or more approaches to arrive at a combination of formula and process that result in product with good organoleptic properties.

 

Downloads

Download data is not yet available.

Author Biographies

Santosh Kumar Bhatt, Department of pharmaceutics, Oxbridge college of Pharmacy, Bengaluru -560091, Karnataka, India

Department of pharmaceutics, Oxbridge college of Pharmacy, Bengaluru -560091, Karnataka, India

Kedarnagalakshman M, Department of pharmaceutics, Oxbridge college of Pharmacy, Bengaluru -560091, Karnataka, India

Department of pharmaceutics, Oxbridge college of Pharmacy, Bengaluru -560091, Karnataka, India

 

Mukesh Sharma, Department of pharmaceutics, Oxbridge college of Pharmacy, Bengaluru -560091, Karnataka, India

Department of pharmaceutics, Oxbridge college of Pharmacy, Bengaluru -560091, Karnataka, India

References

1. VermaP,ThakurAS, DeshmukhK, Jha AK,Verma S.Routes of drug administration. Int J Pharm Stud Res2010; I(I):54-59.
2. Davies P. Oral solid dosage forms. In: Mark Gibson. (ed.) Pharmaceutical preformulation and formulation. 2ndEd. New York: Informa Healthcare 2009; 367-70.
3. Darji MA, Lalge RM, Marathe SP, Mulay TD, Fatima T, Alshammari A, et al. Excipient stability in oral solid dosage forms: Areview.AAPS Pharm SciTech 2018;19(1):12-26.
4. Banker GS, Anderson NR. Tablets In: Lachman L, Lieberman HA, Kanig JL. (eds.) TheTheory and Practice of Industrial Pharmacy. 3rdEd. Mumbai: Varghese Publishing House1987:329-35.
5. Michele TM, Knorr B, Vadas EB, Reiss TF. Safety of chewable tablets for children. JAsthma.2002; 39(5):391-403.
6. Chinwala M.Recent formulation advances and therapeutic usefulness of orally disintegrating tablets (ODTs). Pharmacy(Basel).2020; 8(4):186.
7. Augsburger LL, Hoag SW. Pharmaceutical Dosage forms -Tablets. 3rdEd. New York: In forma health care USAInc2008:309-415.
8. Mendes RW. Chewable tablets. In: Lieberman HA, LachmanL, Schwartz JB.(eds.)Pharmaceutical dosage forms. Tablets. 2ndEd. New York: Marcel Dekker. Inc 1989:367-415.
9. Renu, Dahiya J, Jalwal P, Singh B. Chewable Tablets: A comprehensive review. PharmaInnovJ2015; 4(5):100-5.
10. Patel H, Shah V, Upadhyay U. New pharmaceutical excipients in so lid dosage forms. IntJPharmLifeSci2011; 2(8):1-8.
11. Gennaro AR, Remington: The science and practice of pharmacy. Maryland, USA.20th Edn 2003; 1:889-94.\
12. Kathiresan K, Vijin P, Moorthi C, Manavalan R. Formulation and evaluation of loratadine chewable tablets. Res J Pharm BioChem Sci 2010; 1(4):765.
13. Becker DE, Reed KL. Local anesthetics: review of pharmacological considerations. Anesth Prog. 2012; 59(2):90-103.
14. Becker DE, Reed KL. Essentials of local anesthetic pharmacology. AnesthProg.2006; 53(3):98-110.
15. Malamed SF, Sykes P, Kubota Y, Matsuura H, Lipp M. Local anesthesia: a review. Anesth Pain Control Dent.1992;1(1):11-24

Published

2021-08-15

How to Cite

Bhatt, S. K., M, K., & Sharma, M. (2021). THE Role of Chewable Tablets: An Overview: Eprosartan, LC/MS-MS, Validation, Plasma. Asian Journal of Pharmaceutical Research and Development, 9(4), 141–146. https://doi.org/10.22270/ajprd.v9i4.1005

Most read articles by the same author(s)